Pharmaceutical Market Research Reports & Industry Analysis
Our coverage in Pharmaceuticals Industry includes large MNC pharmaceutical companies, mid-sized & specialty pharmaceutical companies, off patent or generic drug manufacturers, biotechnology and life sciences companies, contract research companies. We also cover regulatory guidance, contract sales, manufacturing technologies and raw materials in the pharmaceuticals space.
The extensive research & analysis provides us with insight that is a valuable resource for decision-making in this highly vital sector. Our approach and methodology is will enable you a quick and effective understand the key insights of Pharmaceuticals Industry, thus enabling you to respond as market evolves.
Browse reports in Pharmaceutical
Displaying 351 to 380 (of 3130 records)
|
Ability Pharma, SL Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Ability Pharma, SL Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Ability Pharma, SL Product Pipeline Review 2012 provides data on the Ability Pharma, SLs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant...
|
$1500 |
|
Afferent Pharmaceuticals, Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Afferent Pharmaceuticals, Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Afferent Pharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the Afferent Pharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and...
|
$1500 |
|
Benitec Biopharma Limited Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Benitec Biopharma Limited Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Benitec Biopharma Limited Product Pipeline Review 2012 provides data on the Benitec Biopharma Limiteds research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on...
|
$1500 |
|
Biotec Pharmacon ASA Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Biotec Pharmacon ASA Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Biotec Pharmacon ASA Product Pipeline Review 2012 provides data on the Biotec Pharmacon ASAs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant...
|
$1500 |
|
BIOPROJET SCR Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
BIOPROJET SCR Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, BIOPROJET SCR Product Pipeline Review 2012 provides data on the BIOPROJET SCRs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. ...
|
$1500 |
|
Asubio Pharmaceuticals, Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Asubio Pharmaceuticals, Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Asubio Pharmaceuticals, Inc. Product Pipeline Review 2012 provides data on the Asubio Pharmaceuticals, Inc.s research and development faocus. The report includes information on current developmental pipeline, complete with latest updates, and features on...
|
$1500 |
|
Aslan Pharmaceuticals Pte. Ltd. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Aslan Pharmaceuticals Pte. Ltd. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Aslan Pharmaceuticals Pte. Ltd. Product Pipeline Review 2012 provides data on the Aslan Pharmaceuticals Pte. Ltd.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and...
|
$1500 |
|
Agile Therapeutics, Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Agile Therapeutics, Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Agile Therapeutics, Inc. Product Pipeline Review 2012 provides data on the Agile Therapeutics, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued...
|
$1500 |
|
Accera, Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Accera, Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Accera, Inc. Product Pipeline Review 2012 provides data on the Accera, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. ...
|
$1500 |
|
Altacor Ltd. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Altacor Ltd. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Altacor Ltd. Product Pipeline Review 2012 provides data on the Altacor Ltd.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. ...
|
$1500 |
|
Amorfix Life Sciences Ltd. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Amorfix Life Sciences Ltd. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Amorfix Life Sciences Ltd. Product Pipeline Review 2012 provides data on the Amorfix Life Sciences Ltd.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on...
|
$1500 |
|
Cytochroma Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Cytochroma Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Cytochroma Inc. Product Pipeline Review 2012 provides data on the Cytochroma Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. ...
|
$1500 |
|
Cold Genesys, Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Cold Genesys, Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Cold Genesys, Inc. Product Pipeline Review 2012 provides data on the Cold Genesys, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant...
|
$1500 |
|
CrystalGenomics, Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
CrystalGenomics, Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, CrystalGenomics, Inc. Product Pipeline Review 2012 provides data on the CrystalGenomics, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and...
|
$1500 |
|
Hybrigenics S.A. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Hybrigenics S.A. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Hybrigenics S.A. Product Pipeline Review 2012 provides data on the Hybrigenics S.A.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant...
|
$1500 |
|
Intellect Neurosciences, Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Intellect Neurosciences, Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Intellect Neurosciences, Inc. Product Pipeline Review 2012 provides data on the Intellect Neurosciences, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features...
|
$1500 |
|
SRI International Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
SRI International Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, SRI International Product Pipeline Review 2012 provides data on the SRI Internationals research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant...
|
$1500 |
|
Takara Bio Inc. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Takara Bio Inc. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Takara Bio Inc. Product Pipeline Review 2012 provides data on the Takara Bio Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. ...
|
$1500 |
|
Stem Cell Therapeutics Corp. Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
Stem Cell Therapeutics Corp. Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, Stem Cell Therapeutics Corp. Product Pipeline Review 2012 provides data on the Stem Cell Therapeutics Corp.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on...
|
$1500 |
|
RESprotect GmbH Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
RESprotect GmbH Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, RESprotect GmbH Product Pipeline Review 2012 provides data on the RESprotect GmbHs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. ...
|
$1500 |
|
ReNeuron Group plc Product Pipeline Review 2012
Dec 2012 | By - Global Markets Direct
ReNeuron Group plc Product Pipeline Review 2012
Summary
Global Market Directs pharmaceuticals report, ReNeuron Group plc Product Pipeline Review 2012 provides data on the ReNeuron Group plcs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant...
|
$1500 |
|
EpiCast Report: Osteoporosis - Epidemiology Forecast to 2022
Dec 2012 | By - GlobalData
EpiCast Report: Osteoporosis Epidemiology Forecast to 2022
Summary
The lifetime risk of osteoporotic fracture is 50% in women and 10%30% in men (Randell et al., 1995). The morbidity and mortality associated with osteoporotic fractures make osteoporosis a global health burden, second only to cardiovascular disease (Woolf, 2000). Over the next decade, there will be a...
|
$3995 |
|
EpiCast Report: Human Immunodeficiency Virus - Epidemiology Forecast to 2022
Dec 2012 | By - GlobalData
EpiCast Report: Human Immunodeficiency Virus Epidemiology Forecast to 2022
Summary
Human immunodeficiency virus (HIV) is a retrovirus that infects cells of the immune system, destroying or impairing their function. The most advanced stage of HIV infection is acquired immunodeficiency syndrome (AIDS). Approximately 34 million people are living with HIV around the...
|
$3995 |
|
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2012
Dec 2012 | By - GlobalData
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2012" provides data on the Diabetic Foot Infection (DFI) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Foot...
|
$2500 |
|
Astrocytoma Global Clinical Trials Review, H2, 2012
Dec 2012 | By - GlobalData
Astrocytoma Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, Astrocytoma Global Clinical Trials Review, H2, 2012" provides data on the Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Astrocytoma. It includes an overview of the trial numbers and their...
|
$2500 |
|
Multiple Myeloma (Kahlers Disease) Global Clinical Trials Review, H2, 2012
Dec 2012 | By - GlobalData
Multiple Myeloma (Kahlers Disease) Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, Multiple Myeloma (Kahlers Disease) Global Clinical Trials Review, H2, 2012" provides data on the Multiple Myeloma (Kahlers Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...
|
$2500 |
|
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2012
Dec 2012 | By - GlobalData
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2012" provides data on the Glioblastoma Multiforme (GBM) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glioblastoma...
|
$2500 |
|
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2012
Dec 2012 | By - GlobalData
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2012" provides data on the Acute Respiratory Distress Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...
|
$2500 |
|
Gallbladder Cancer Global Clinical Trials Review, H2, 2012
Dec 2012 | By - GlobalData
Gallbladder Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, Gallbladder Cancer Global Clinical Trials Review, H2, 2012" provides data on the Gallbladder Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gallbladder Cancer. It includes an overview of the...
|
$2500 |
|
Hepatic (Liver) Tumor Global Clinical Trials Review, H2, 2012
Dec 2012 | By - GlobalData
Hepatic (Liver) Tumor Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, Hepatic (Liver) Tumor Global Clinical Trials Review, H2, 2012" provides data on the Hepatic (Liver) Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic (Liver) Tumor. It includes an...
|
$2500 |
Displaying 351 to 380 (of 3130 records)
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Main Category
Popular Reports
- Asia Pacific Renewable Energy Policy Handbook 2012
- Research Report on China's Polyester Industry Chain, 2013-2017
- Plastic Additives Market - Global Industry Analysis, Size, Share, Growth And Forecast, 2011 - 2016
- PC and Online Gaming Industry in India 2012
- Computed Radiography and Digital Radiography Market in Europe 2011-2015
- Home Healthcare Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
- Building Integrated Photovoltaics Markets 2012
- Gaming Market - Global Industry Analysis, Size, Growth, Share & Forecast, 2011 - 2015
- Water Treatment Chemicals And Technology Market - Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2011 - 2018
- Synthetic And Bio-Based Biodegradable Plastics - Global Industry Analysis, Market Size, Applications, Share, Growth And Forecast, 2011 - 2018







